Video

Dr. Young on the Challenges of Using Anticoagulants in Children With Cancer

Author(s):

Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, discusses the challenges of using anticoagulants in children with cancer.

Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, discusses the challenges of using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is challenging because children have a higher risk of experiencing day-to-day trauma, says Young. Traumas such as a scraped knee are a normal occurrence for children, but when on an anticoagulant, the risk of bleeding is much higher.

Related Videos
Robert M. Rifkin, MD, FACP
Renier Brentjens, MD, PhD,
Jian Zhang, MD
Carsten Niemann, MD, PhD, chief physician, and head of Laboratory at the Rigshospitalet Copenhagen University Hospital.
Jae Park, MD
David A. Braun, MD, PhD
Bradley McGregor, MD,
Francisco J. Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine – Lymphoma, director, Lymphoma Research, head, Lymphoma Translational Research Lab, associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Monica H. Vetter, MD